Methods for non-invasive retrieval of viable (i.e., able to be fertilized) oocytes from the uterus via a combination of unique ovarian stimulation and uterine lavage technology. These methods may eliminate the need for an invasive surgical procedure. Embodiments include the use of a novel hormonal protocol, including the use of injectable gonadotropins, to induce the release of immature oocytes from the ovaries of a patient. The immature oocytes mature as they transit the fallopian tubes such that mature, viable oocytes may be collected from the uterus via a uterine lavage procedure. Further embodiments include the use of a novel hormonal protocol, including the administration of Prostaglandins, Estradiol, and/or Progesterone Blockers, to accelerate transport of oocytes through the fallopian tubes. Further embodiments include kits for uterine lavage, compositions suitable for triggering and inducing superovulation, and compositions suitable for accelerating tubal transport of mature oocytes in a female patient.

An intelligent baby caring method and arrangement helps to recognize and maintain emotional interaction between mother and her baby and to improve the baby's life rhythm and calm and soothe him/her automatically when needed and help him/her to fall asleep and to wake up at the most convenient time and way. The aim is to help the mother with her baby to find optimal life and care rhythm. The invention is focused on a platform (101) with many sensors, sensor sheet (120), a transducer to produce acoustic and mechanical vibrations (14) and an airflow blower (132). Sensors are also fixed to the mother (10) and in the care room (198). A sleep/activity graph of the baby and sleep/emotion graph of the mother are measured and tracked with multimodal sensors and an artificial intelligence unit (200) processes audio, motion and airflow actions given to the baby from the platform to help the baby to move from an improper to optimal sleep/activity level.

A trocar assembly for uterine and fetal surgeries includes a cannula defining a hollow tubular sleeve that extends from a first open end to a second open end, a hollow obturator defining a shaft that extends from a first open end that is tapered to a second open end, wherein the hollow obturator is located within the cannula, and wherein the trocar assembly is configured to be inserted into a patient's body to give access to a bodily cavity, such as the uterine cavity (amniotic cavity) or the fetus. The trocar assembly is configured for insertion into the uterine cavity using the Seldinger technique.

A trocar assembly and method for uterine and fetal surgeries includes a cannula defining a hollow tubular sleeve that extends from a first open end to a second open end, a hollow obturator defining a shaft that extends from a first open end that is tapered to a second open end, wherein the hollow obturator is located within the cannula, and wherein the trocar assembly is configured to be inserted into a patient's body to give access to a bodily cavity, such as the amniotic cavity or the fetus. The trocar assembly is configured for insertion into the amniotic cavity using the Seldinger technique.

A trocar assembly and method for uterine and fetal surgeries includes a cannula defining a hollow tubular sleeve that extends from a first open end to a second open end, a hollow obturator defining a shaft that extends from a first open end that is tapered to a second open end, wherein the hollow obturator is located within the cannula, and wherein the trocar assembly is configured to be inserted into a patient's body to give access to a bodily cavity, such as the amniotic cavity or the fetus. The trocar assembly is configured for insertion into the amniotic cavity using the Seldinger technique.

A process for recovering one or more blastocysts from a uterus of a human includes a step of placing a device transvaginally into a cervical canal of the patient; a step of delivering fluid through the device to the uterus and applying a vacuum to a uterus of the patient to aspirate fluid and entrained one or more blastocysts from the uterus; and a step of performing a biopsy procedure on the one or more recovered blastocysts to remove one or more of trophectoderm cells or inner cell mass from the recovered blastocysts. The process may further include a step of storing one or more of the biopsied trophectoderm cells or inner cell mass following the biopsy procedure and a step of performing at least one molecular diagnostic assay test on the one or more of the biopsied trophectoderm cells or inner cell mass.

In one embodiment, a method for performing meningeal repair includes closing an open meningeal defect with a human umbilical cord meningeal patch.

A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption. Kits and uterine lavage systems are further provided for performing the processes described in the invention.

A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption. Kits and uterine lavage systems are further provided for performing the processes described in the invention.

A medical device includes: an elongated member having a first end, a second end, and a body extending between the first end and the second end; a first anchor coupled to the first end of the elongated member; and a second anchor coupled to the second end of the elongated member; wherein the elongated member is configured for placement across an abdominal wall of a fetus, and wherein the elongated member is elastically stretchable to accommodate for a growing thickness of the abdominal wall of the fetus.